Diminished Virulence Rabbit Model of Endocarditis: of Mutant of Staphylococcus
Diminished Virulence Rabbit Model of Endocarditis: of Mutant of Staphylococcus
Diminished Virulence Rabbit Model of Endocarditis: of Mutant of Staphylococcus
1172/JCI117530
Harbor-UCLA Medical Center, the UCLA School of Medicine, Torrance, California 90509; and § The Veterans Affairs Medical Center,
UCSF, San Francisco, California 94121
studies with RN6390-related strains in the rabbit endocarditis described (21). PMP was added to washed bacterial suspensions in low
model, there was a significant reduction in infectivity rates protein-binding microtiter plates (Corning Glassworks, Corning, NY)
across a broad range of challenging inocula (103- 106 CFU) to achieve a final PMP concentration of 100 U/ml and a final bacterial
inoculum of 103 CFU/ml. After 2 h of incubation at 370C, 20-pl
-
with the double mutant when compared to the corresponding aliquots were processed for quantitative culture as described previously
sar'/agr' (parent) strain. These results suggest that both loci (21). The percent bacterial survival was calculated for each S. aureus
are involved in the initiation and persistence of S. aureus infec- strain. Bacillus subtilis (ATCC 6633), a highly PMP-susceptible strain,
tion in the fibrin-platelet-endothelial matrix in endocardial vege- served as a positive control for PMP bioactivity while wells containing
tations. the organism plus minimal essential medium (Irvine Scientific, Santa
Ana, CA) alone were used as negative controls (23).
Methods Southern blot hybridization. S. aureus DNA was prepared from
lysostaphin-lysed cells as described (12). Chromosomal DNA was di-
Bacterial strains, plasmids, DNA probes, and phage. The bacterial gested with selected restriction enzymes (New England BioLabs, Bev-
strains, plasmids and DNA probes used in this study are listed in Table erly, MA), transferred onto Hybond N' membrane (Amersharn, Arling-
I. Phage 411 was used as a transducing phage for RN6390 and RN450. ton Heights, IL) and hybridized at 650C with probes labeled with 32p
Media and antibiotics. CYGP, 0.3GL, and Brain-Heart-Infusion by the random-primed method (Ready to Go Labeling Kit; Pharmacia
(Difco Laboratories Inc., Detroit, MI) were used for the growth of Fine Chemicals, Piscataway, NJ) or the nick translation method (Nick
bacteria (12). Antibiotics were used at the following concentrations: Translation Kit; Boehringer Mannheim, Indianapolis, IN). After hybrid-
erythromycin at 10 jig/ml and tetracycline at 5 jig/ml. ization, the membrane was washed with SSPE (10 mM NaH2PO4, 150
Transduction. Phage 411 was used to prepare lysates of strain mM NaCl, 1 mM EDTA, pH 7.4) according to the membrane manufac-
RN6911 (14) which is an agr- mutant of parental strain RN6390 (12). turer's instructions (12) and autoradiographed with an intensifying
The phage lysate was used to infect sar- mutants R and A (15) derived screen at -70'C.
from strains RN6390 and RN450, respectively, at a low multiplicity of Northern blot hybridization. S. aureus RNA was prepared using a
infection (phage to recipient ratio = 1:10). Transductants carrying the modification of the method of Kornblum et al. (24) as previously de-
double mutations were selected on 0.3 GL agar containing both erythro- scribed (15). For Northern blots, equal volumes (7.5 1tl) of RNA samples
mycin and tetracycline. The 411 lysate of RN691 1 was also used to extracted from an equivalent number of bacterial cells were electropho-
infect strain RN450 to obtain tetR transductants carrying the agr mutation resed through a 1.5% agarose-0.66 M formaldehyde gel in MOPS run-
alone. ning buffer as described (15). The intensity of the 23 S and 16 S
Phenotypic characterization. For phenotypic characterization, the ribosomal RNA bands stained with ethidium bromide was verified to
measurements included a; ,3; and 5-hemolysin production on sheep and be equivalent among all samples before transfer. RNA was transferred
rabbit erythrocyte agar as previously described (16), lipase production to Hybond N (Amersham), cross-linked with UV light, allowed to hy-
as measured on 1% Tween 20 agar plates (12), fibronectin binding bridize with a 32P-labeled gel purified DNA probes (25) in 50% for-
capacity as assayed by 251I-labeled fibronectin binding (17), and fibrino- mamide at 420C overnight, washed, and autoradiographed as de-
gen binding capacity as determined by 125I-labeled fibrinogen bind- scribed (15).
ing (18). Animal model of endocarditis. All bacterial strains were grown in
To determine whether the double mutant differed from either the brain-heart infusion broth at 370C overnight with rotation (30 rpm)
parent or single isogenic mutants in other phenotypic traits likely to be supplemented with appropriate antibiotics if necessary. In preliminary
important in endocarditis pathogenesis, we studied the comparative in studies, it was determined that the growth rates of parental and mutant
vitro ability of these strains to: (a) adhere to platelets as measured by strains were almost identical both in the presence and absence of antibi-
flow cytometry (19, 20); and (b) resist the bactericidal action of platelet otics over a 24-h period. In our previous study with a sar- mutant (13),
microbicidal protein (PMP)' (21). we established that incorporation of antibiotics into the overnight growth
For platelet adherence assays, rabbit whole blood was collected media did not influence the ability of the strain to induce experimental
into polypropylene tubes containing sodium citrate (5:1) and 1 pg/ml endocarditis. Overnight cultures were harvested by centrifugation (2,000
prostaglandin E1 (PGEI) (Sigma Chemical Co., St. Louis, MO) to miti- g for 10 min), washed twice in sterile normal saline and resuspended
gate platelet activation. Platelets were isolated by centrifugation (150 g in saline to an OD62Nm of 1.6 (- 1 x 109 CFU/ml). This bacterial
for 10 min) and labeled externally with P2 (2.5 Ag/ml), an FITC-conju- suspension was serially diluted in saline to 103-106 CFU/ml. Each
-
gated monoclonal antibody against CD41 (AMAC, Westbrook, ME), dilution was confirmed by quantitative culture on blood agar plates.
or internally labeled with 5 jiM 5-chloromethylfluorescein diacetate Endocarditis on the aortic valve of New Zealand White rabbits (2-
(CMFDA; Molecular Probes, Eugene, OR). After 1 h of incubation, the 2.5 kg) was induced by a modification of the method of Durack and
platelets were washed and suspended in Tyrode's solution as previously Beeson (26). In brief, rabbits were anesthetized by intramuscular injec-
described (22). To label bacteria, overnight cultures of each strain were tion of ketamine chloride (Aveco Inc., Fort Dodge, IA) at 35 mg/kg
washed in Tris-EDTA-NaCl buffer (0.05 M Tris-HCl with 0.1 M NaCl and xylazine (Mobay Corp., Shawnee, KS) at 1.5 mg/kg. A polyethylene
and 0.02 M EDTA, pH 7.2) and labeled for 3 h with Hoechst 33342 catheter with an internal diameter of 0.86 mm (Becton Dickinson, Cor-
dye (25 1ig/ml; Polysciences, Warrington, PA), a DNA-binding fluoro- keysvilie, MD) was introduced into the left ventricle via the right carotid
chrome (22). Adherence studies were performed at 20°C by mixing
bacteria and platelets in Tyrode's salts solution (Sigma Chemical Co.) artery to produce sterile thrombotic endocarditis. To induce endocarditis,
at a bacterial/platelet ratio of 10:1. One minute after mixing, the suspen- groups of 10-15 animals each were challenged intravenously at 48
-
sions were analyzed using a FACSta?'P" (Becton Dickinson, San Jose, h after catheterization with various inocula of different bacterial strains
CA) cytofluorograph, using predetermined combinations of argon lasers, (103-106 CFU). Catheters remained in place until animals were sacri-
excitatory wavelengths, and appropriate filters (19, 22). The percentage ficed by lethal injection of sodium pentobarbital (100 mg/kg) at 48 h
of bacteria adhering to platelets was determined as previously de- after bacterial challenge. Animals with macroscopic valvular vegetations
scribed (19). and proper catheter placement were analyzed for data in this study. At
For the second assay, PMP was prepared from thrombin-stimulated time of sacrifice, aortic valves and left ventricular vegetations were
platelet-rich plasma and assayed for bioactivity (U/ml) as previously removed, pooled, weighed, homogenized in 0.5 ml of normal saline
and quantitatively cultured in antibiotic-free medium (for all strains),
erythromycin-containing medium (for mutant R and I), tetracycline-
containing medium (for RN6911 and mutant I) or medium containing
1. Abbreviation used in this paper: PMP, platelet microbicidal protein. both antibiotics (double mutant). Animals with negative cultures of
Bacterial strains
S. aureus
DB 12 A wild-type blood isolate that is the parent of the original sar- mutant 1D2.
11D2 12 An isogenic mutant of strain DB with a sar::Tn9l7LTV1 mutation
RN6390 40 A prototypic strain that maintains its hemolytic pattern when propagated on sheep erythrocyte agar.
Mutant R 15 An isogenic mutant of RN6390 carrying a sar.:Tn9l7LTVl mutation.
RN6911 14 An isogenic mutant of RN6390 with an agr::getM mutation.
Mutant I This study A derivative of RN6390 carrying both sar::Tn9J7LTV1 and agr::tetM mutations.
RN450 40 A prototypic strain, which is a derivative of NCTC 8325 cured of prophages, secretes /3 hemolysin
but not a hemolysin.
Mutant A 15 An isogenic mutant of RN450 with a sar.:Tn9J7LTVI mutation.
Mutant D This study An isogenic mutant of RN450 with a agr::tetM mutation.
Mutant AD This study A double mutant of RN450 with both sar::Tn917LTVl and agr.:tetM mutations.
E. coli with plasmids
DU5384 41 An E. coli strain carrying a pBR322 plasmid with a 3-kb EcoRI-HindIII fragment of the a-hemolysin
gene to be gel-purified to be used as a probe.
RN6929 42 JM109 containing a pBluescript plasmid with a 2.2-kb Clal fragment of the /3-hemolysin gene which
was gel-purified to be used as a probe.
DNA probes
pLTVl 12, 43 A derivative of Tn9J7 carrying a E. coli replicon. A 1.5-kb Hindu gel-purified fragment was used as
a probe.
pALC4 31 A shuttle plasmid (pSPT181) containing a 732-bp PCR fragment of sarA gene of RN6390.
pMVN6 44 A pUC8 plasmid carrying a 2.9-kb BamHI fragment of tetM.
hld probe This study A 51 1-bp PCR fragment of the RNAIII from nucleotides 1265-1775 based on published sequence
(9).
agrA probe This study A 513-bp PCR fragment of the agrA gene from nucleotides 3830-4342 (9).
Table II. Phenotypic Characterization of RN6390, RN450, and Their Corresponding sar/agr Mutants
Strains
RN6390 RN6911 Mutant R Mutant I RN450 Mutant D Mutant A Mutant AD
Phenotypes* sar+lagr+ sar+/agr7 sar-lagr+ sar-lagr- sar+lagr+ sar+lagr- sar-lagr+ sar-lagr-
a-Hemolysin ++- - - - - - -
,B-Hemolysin ++ + + - + +
6-Hemolysin ++ - - - +--
Lipase + - ++
Fibronectin binding
protein' 3314±35 4059±117 2636±80 2809±60 15221±671 26852±691 4874±192 4909±611
Fibrinogen binding
protein11 5694±70 5427±314 5156±94 5118±118 6139±119 5326±103 3463±449 3094±97
Susceptibility to PMP (%
survival) 0% 0% 0% 1.3%
Platelet binding by FACS
(% bound)1 61.7±39.7 57.3±42 69.1±26.6 72.8±26.1
* + +, strong producer; +, moderate producer; +/-, very weak producer; -, non producer. * The expression of a-hemolysin in these strains was
also confirmed by immunoblots of extracellular proteins probed with affinity purified anti-a-hemolysin antibody (Toxin Technology, Sarasota, FL).
tData are presented as cpm of l"I-fibronectin bound to 109 CFU. Values are given as mean+SEM (n = 4). The reduction in fibronectin binding
of double mutants I and AD in comparison with the respective parental strains is statistically significant (P 5 0.009 and 0.001 for mutant I and
AD, respectively; t test). The augmentation in fibronectin binding as a result of the agr mutation alone (RN6911 and mutant D) was also significant
when compared to the respective parents (P 0.004 and 0.001 for RN6911 and mutant D, respectively; t test). 11 Data are given as cpm of
-
12'I-fibrinogen bound to 109 CFU and are reported as the mean±SEM (n = 4). The binding of radiolabeled fibrinogen to double mutants I and AD
was lower than that of the respective parental strain (P 5 0.023 and 0.0001 for mutants I and AD, respectively; t test). Similarly, sarf mutant A
bound less radiolabeled fibrinogen than parent strain RN450 (P 5 0.008). 1 Platelets labeled with P2 or CMFDA were bound comparably by all
strains.
Figure 2. Northern blots of a- (A) and /B- (B) hemolysin transcripts of At 48 h after catheterization, bacteria were injected directly into the
parental strain (RN6390) and the corresponding sarlagr mutants. The marginal ear veins. All rabbits were sacrificed for morphological exami-
positive control in A is a pBR322 plasmid carrying a 3-kb EcoRI- nation and valvular cultures at 48 h after bacterial challenge. Values
HindII fragment of the a-hemolysin gene (41). In B, the positive control aregiven as numberwithendocarditis/total numberinthegroup. * Statis-
is a pBluescript plasmid with a 2.2-kb Clal fragment of the /3-hemolysin tically significantly when compared with sar'lagr' parental strain (P
gene (42). c 0.03; Fisher Exact test). t When compared with the parental strain,
induction rates are significant with the P values < 0.0001 and 0.015 at
103 and 104 inocula, respectively. § Induction rates are significantly
lower than that of the parental strain at all inocula (P values of 0.00006,
mutation in both strains (see mutants R and A in Table II). 0.0015, 0.002, and 0.03 at 103- 106 CFU, respectively).
However, the effect of the agr mutation alone on fibrinogen
binding capacity was more variable, with one resulting in a
slight reduction (mutant D) while the other one remaining un- plating methods. As shown in Fig. 3, animals challenged with
changed (RN691 1). the double sar-lagr- mutant had significantly lower vegetation
In preliminary studies, it was determined that strain RN6390 densities as compared with the sar'/agr' parent at all challenge
was virulent in the animal endocarditis model (see below). inocula. At the two higher inocula (105- 106), challenge with
Based on this finding, we evaluated other phenotypic traits in the sar-lagr' strain yielded lower bacterial densities in aortic
RN6390 and its corresponding mutants that are likely to be vegetations than the sar'/agr' parent. Although the mean bacte-
important in the pathogenesis of endocarditis, including suscep- rial vegetation densities achievable with the sar+lagr- mutant
tibility to PMP (19) and the ability to bind platelets (27, 28). were lower than the parent at higher challenge inocula (105-
As seen in Table H, all strains were very susceptible to the 106 CFU), they did not reach statistical significance.
killing action of PMP. After exposure to PMP at 100 U/ml for To verify the stability of the sar and agr mutations in mutant
120 min, the mean survival among these strains was between strains after animal passage, chromosomal DNA of sar'lagr+
0 and 1.3%. Likewise, the ability to bind platelets as assayed (parent), sar+/agr-, sar-/agr+, and sar-/agr- colonies isolated
by FACS was similar among all strains studied (Table H).
Animal model of endocarditis. In pilot studies, it was deter-
mined that the ID,0 for parental strain RN6390 was between
103 and 104 CFU. The induction rates for endocarditis with I SD
parent RN6390 and its corresponding mutants were evaluated
* Mean --
at various intravenous challenge inocula between 103 and 106 ....
otic-free media. Our results indicated that there were no differ- - (P - 0.05), +/+ vs -/+ (P - 0.05). * The vegetation cultures in
ences in quantitative recovery of bacteria between these two these animal groups were negative.
second possibility is that the sar and agr loci control the expres- achieved lower intravegetation bacterial densities than the par-
sion of cell wall proteins via different regulatory mechanisms ent. Whether this reduction in intravegetation bacterial densities
such that a malfunctioning sar locus, irrespective of the func- is due to a diminution in cytotoxin secretion (e.g., hemolysins)
tionality of the agr locus, will lead to downregulation of cell and/or a decline in initial adhesion observed in these mutants
wall proteins. is not resolved in this study. Nevertheless, a-hemolysin, a pore-
As inactivation of both sar and agr loci resulted in reduced forming cellular cytotoxin, has been shown to exhibit lethality
production of extracellular and cell wall proteins that are puta- for platelets and endothelial cells (38, 39), two important com-
tive virulence determinants in S. aureus (5, 7), we evaluated ponents of the vegetation in endocarditis (33). It is conceivable
the net in vivo effect of a double mutant in a rabbit model of that the absence of a hemolysin in a mutant strain may adversely
endocarditis. Our data showed that the double mutant had a affect its ability to persist within vegetation. Because very few,
lower capacity to induce endocarditis as compared to the parent if any, leukocytes are found within infected aortic vegetations
strain at all challenge inocula (Table HI). Moreover, the vegeta- in both experimental and human endocarditis (33), any dissimi-
tion bacterial densities were markedly decreased in the double larity in cellular immune response between the parent vs the
mutant in comparison with the parent strain at all challenge mutant strains is unlikely to explain the observed differences
levels. In contrast, the sar-lagr' mutant induced endocarditis in induction rates or intravegetation bacterial densities. As these
at a significantly lower rate than the parent strain only at the two regulatory loci control the synthesis of a variety of extracel-
two lower challenge inocula (103-104 CFU). This induction lular and cell wall proteins, our data would seem to support the
rate is in concordance with our previous studies in which a multifactorial nature involved in the pathogenesis of S. aureus
different single sar- mutant (strain 1 1D2) had a lower induction endocarditis.
rate than the isogenic parent only at such challenge inocula Considerable efforts have been spent previously to single
(13). Interestingly, the induction rate for sar'/agr- strain dif- out a specific virulence factor in the pathogenesis of S. aureus
fered from the parent only at the 103 CFU inoculum. Although endocarditis and other related intravascular infections. How-
the induction rates for single sar mutant were statistically equiv- ever, these experimental approaches have not been successful
alent to those of the parent strain at the higher challenge inocula in explaining the range of this organism's ability to induce and
(105-106 CFU), the mean vegetation bacterial densities were propagate infections at a challenging inoculum found in similar
substantially lower in the sar mutant group, but not in the agr human infections (4, 7). For example, in experiments involving
mutant group, when compared to the parental group at these inactivation of the fibronectin binding protein alone, the contrib-
inocula (Fig. 3). utory role of this protein in endocarditis virulence is modest at
Differences in the ability of the double mutant and parental best even at a fairly high challenge inoculum (106 CFU) (7).
strains to induce endocarditis as described here may be related Based on these investigations, it appears that S. aureus may have
to potential perturbations in either of the two critical events a wide arsenal of adhesins and toxins to facilitate adherence and
in the pathogenesis of endocarditis: initial adherence to sterile propagation within human valvular tissues. In this study, we
vegetation and/or subsequent intravegetation bacterial propaga- have shown that the sar and agr loci of S. aureus are important
tion (26, 32). Within the matrices of the valvular vegetations, regulatory elements in the expression of virulence determinants
fibrinogen, fibronectin, vitronectin, platelets, and released plate- necessary for the induction and propagation of intravegetation
let proteins (e.g., thrombospondin) are commonly deposited (5, growth in the animal model. Hence, it may be meaningful to
7, 32). In addition, underlying extracellular matrix proteins, target these regulatory loci for the development of novel antimi-
such as collagen and laminin, may also be exposed as a result crobial agents (e.g., designing a synthetic analog to block activa-
of prior endothelial damage (33, 34). During the initial phase tion of virulence factors by the native sar gene products).
of bacteremia, a combination of impaired fibronectin and fi- One of the genes (sarA) within the sar locus has recently
brinogen binding may conceivably contribute to a reduction in been cloned (31). Sequence analysis revealed an open reading
the number of initial adherence events at the vegetation surface frame of 372 bp with a predicted mol wt of 14,718 D. Additional
for the double mutant. Notably, this diminished capacity to studies indicated that this gene is necessary for the optimal
bind fibronectin and fibrinogen in the double mutant is likely transcription of RNAIII (31). In this current study, there is
attributable to a mutation in the sar locus (Table II). This con- additional evidence to suggest that both agr-dependent and agr-
cept is consistent with the experimental observation that at independent pathways are probably operational in the regulation
higher inocula (105_-106 CFU), the bacterial vegetation densities of virulence determinants in S. aureus. To our knowledge, this
achievable by the single sar mutant, but not the single agr is the first study that implicates both regulatory loci (i.e., sar and
mutant, were significantly lower than the parent despite compa- agr) in early bacterial adherence, induction, and intravegetation
rable induction rates (Fig. 3). Nevertheless, the possibility that persistence in the pathogenesis of endocarditis. A detailed un-
additional staphylococcal surface receptors such as those for derstanding of the entire sar locus and its mode of regulation
collagen, laminin and thrombospondin (35-37) may be in- will provide insight into the molecular mechanisms of staphylo-
volved in adhesion cannot be entirely ruled out. Our data also coccal pathogenesis and may uncover specific targets which
seem to minimize the role of platelets in accounting for the may be amenable to therapeutic intervention in S. aureus infec-
differences in early adherence between the parent and mutant tions.
strains since they bound equally well to platelets, and were
highly susceptible to platelet-microbicidal-protein-induced le- Acknowledgments
thality in vitro.
After initial adherence to the vegetation surface, the eventual We thank Patrick Ying, Reva Edelstein, and Wendy Foss for technical
establishment of infection is still dependent on the ability of the assistance; and Steven Projan for performing hemolysin assay and gener-
microorganism to proliferate within the vegetations. As noted in ating helpful discussion.
Fig. 3, both the single sar mutant and the double mutant This work was supported in part by Grants-In-Aid from the Ameri-
can Heart Association and the New York Heart Association and by with bacteria. VI. contrasting the role of fibrinogen and fibronectin. Am. J. Hema-
Public Health Service grant A130061 (to A. L. Cheung). M. R. Yeaman tol. 9:43-53.
21. Yeaman, M. R., D. C. Norman, and A. S. Bayer. 1992. Staphylococcus
and A. S. Bayer were supported in part by Grants-In-Aid from the aureus susceptibility to thrombin-induced platelet microbicidal protein is indepen-
American Heart Association (Greater Los Angeles Affiliate) and the St. dent of platelet adherence and aggregation in vitro. Infect. Immun. 60:2368-2374.
John Heart Institute (Los Angeles, CA), respectively. P. M. Sullam was 22. Sullam, P. M., D. G. Payan, P. F. Dazin, and F. H. Valone. 1990. Binding
supported by VA Career Development Program and National Institutes of viridans group streptococci to human platelets: a quantitative analysis. Infect.
of Health grant AI-32506. A. L. Cheung is an Investigator of the New Immun. 58:3802-3806.
York Heart Association and is a recipient of an Irma T. Hirshl Career 23. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer. 1992.
Partial characterization and staphylocidal activity of thrombin-induced platelet
Scientist Award. microbicidal protein. Infect. Immun. 60:1202-1209.
24. Kornblum, J., S. J. Projan, S. L. Moghazeh, and R. Novick. 1988. A rapid
method to quantitate non-labeled RNA species in bacterial cells. Gene. 63:75-
References 85.
25. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning, a
1. Waldvogel, F. A. 1985. Staphylococcus aureus. In Principles and Practice laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
of Infectious Diseases. G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett, 26. Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis.
editors. John Wiley & Sons, New York. 1097-1116. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44-49.
2. Neu, H. C. 1992. The crisis in antibiotic resistance. Science (Wash. DC). 27. Scheld, W. M., J. A. Valone, and M. A. Sande. 1978. Bacterial adherence
257:1064-1072. in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets and
3. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a fibrin. J. Clin. Invest. 61:1394-1404.
post-antibiotic era. Science (Wash. DC). 257:1050-1055. 28. Herzberg, M. C., K. Gong, and G. D. McMarlane. 1990. Phenotypic
4. Easmon, C. S. F., and C. Adlam. 1983. Staphylococci and Staphylococcal characterization of Streptococcus sanguis virulence factors associated with bacte-
Infections. Academic Press, New York. 705-740. rial endocarditis. Infect. Immun. 58:515-522.
5. Cheung, A. L., M. Krishnan, E. A. Jaffe, and V. A. Fischetti. 1991. Fibrino- 29. Cheung, A. L., and V. A. Fischetti. 1990. The role of fibrinogen in
gen acts as a bridging molecule in the adherence of Staphylococcus aureus to staphylococcal adherence to catheters in vitro. J. Infect. Dis. 161:1177-1186.
cultured human endothelial cells. J. Clin. Invest. 87:2236-2245. 30. Herrmann, M., P. E. Vaudaux, D. Pittet, R. Auckenthaler, P. D. Lew, F.
6. Herrmann, M., P. E. Vaudaux, D. Pittet, R. Auckenthaler, P. D. Lew, F. Schumacher Perdreau, G. Peters, and F. A. Waldvogel. 1988. Fibronectin, fibrin-
Schumacher Perdreau, G. Peters, and F. A. Waldvogel. 1988. Fibronectin, fibrin- ogen, and laminin act as mediators of adherence of clinical staphylococcal isolates
ogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158:693-701.
to foreign material. J. Infect. Dis. 158:693-701. 31. Cheung, A. L., and S. J. Projan. 1994. Cloning and sequencing of sarA:
7. Kuypers, J. M., and R. A. Proctor. 1989. Reduced adherence to traumatized a gene required for the expression of agr. J. Bacteriol. 176:4168-4172.
rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. 32. Scheld, W. M., R. W. Strunk, G. Balian, and R. A. Calderone. 1985.
Infect. Immun. 57:2306-2312. Microbial adhesion to fibronectin in vitro correlates with production of endocardi-
8. DeRita, V. J., and J. J. Mekalanos. 1989. Genetic regulation of bacterial tis in rabbits. Proc. Soc. Exp. Biol. Med. 180:474-482.
virulence. Annu. Rev. Genet. 23:455-482. 33. Durack, D. T., and P. B. Beeson. 1980. Pathogenesis of infective endocar-
9. Kornblum, J., B. Kreiswirth, S. J. Projan, H. Ross, and R. P. Novick. 1990. ditis. In Infective Endocarditis. S. H. Rahimtoola, editor. Grune and Stratton, Inc.,
Agr: A polycistronic locus regulating exoprotein synthesis in Staphylococcus New York. 1-53.
aureus. In Molecular Biology of the Staphylococci. R. P. Novick, editor. VCH 34. Jaffe, E. 1987. Cell biology of endothelial cells. Hum. Pathol. 18:234-
Publishers, New York. 373-402. 239.
10. Nixon, B. T., C. W. Ronson, and R. M. Ausubel. 1986. Two component 35. Lopes, J. D., M. D. Reis, and R. R. Bretani. 1985. Presence of laminin
regulatory systems responsive to environmental stimuli share strongly conserved receptors in Staphylococcus aureus. Science (Wash. DC). 229:275-277.
domains with the nitrogen assimilation regulatory genes ntrB and btrC. Proc. 36. Patti, J. M., T. Bremell, D. Krajewska-Paetrasik, A. Adelnour, A. Tarkow-
Natl. Acad. Sci. USA. 83:7850-7854. ski, C. Ryden, and M. Hook. The Staphylococcus aureus collagen adhesin is a
11. Smeltzer, M. S., M. E. Hart, and J. J. Iandolo. 1993. Phenotypic character- virulence determinant in experimental septic arthritis. Infect. Immun. 62:152-161.
ization of xpr, a global regulator of extracellular virulence factors in Staphylococ- 37. Herrmann, M., S. J. Suchard, L. A. Boxer, F. A. Waldvogel, and P. D.
cus aureus. Infect. Immun. 61:919-925. Lew. 1991. Thrombospondin binds to Staphylococcus aureus and promotes staph-
12. Cheung, A. L., J. M. Koomey, C. A. Butler, S. J. Projan, and V. A. ylococcal adhesion to surfaces. Infect. Immun. 59:279-288.
Fischetti. 1992. Regulation of exoprotein expression in Staphylococcus aureus by 38. Bhakdi, S., M. Muhly, U. Mannhardt, F. Hugo, K. Klapettek, C. Muller-
a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA. 89:6462-6466. Eckhardt, and L. Roka. 1988. Staphylococcal a-toxin promotes blood coagulation
13. Cheung, A. L., M. Yeaman, and A. S. Bayer. 1994. The role of the sar via attack on human platelets. J. Exp. Med. 168:527-542.
locus of Staphylococcus aureus in the induction of endocarditis in rabbits. Infect. 39. Suttorp, N., T. Hessz, W. Seeger, A. Wilke, R. Koob, F. Lutz, and D.
Immun. 62:1719-1725. Drenckhahn. 1988. Bacterial exotoxins and endothelial permeability for water and
14. Vandenesch, F., J. Kornblum, and R. P. Novick. 1991. A temporal signal, albumin in vitro. Am. J. Physiol. 255:C368.
independent of agr, is required for hla but not spa transcription in Staphylococcus 40. Novick, R. P. 1991. Genetic systems in staphylococci. Methods Enzymol.
aureus. J. Bacteriol. 173:6313-6320. 204:587-636.
15. Cheung, A. L., and P. Ying. 1994. Regulation of a and fi hemolysins by 41. O'Reilly, M., J. C. S. de Azavedo, S. Kennedy, and T. J. Foster. 1986.
the sar locus of Staphylococcus aureus. J. Bacteriol. 176:580-585. Inactivation of the alpha-hemolysin of Staphylococcus aureus 8325-4 by site
16. Rescei, P., B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and R. P. directed mutagenesis and studies on the expression of its haemolysins. Microb.
Novick. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus Pathog. 1:125-138.
by agr. Mol. & Gen. Genet. 202:58-61. 42. Projan, S. J., J. Kornblum, B. Kreiswirth, S. Moghazeh, W. Eisner, and
17. Froman, G., L. Switalski, P. Speziale, and M. Hook. 1987. Isolation and R. P. Novick. 1989. The 63 hemolysin gene of Staphylococcus aureus. Nucleic
characterization of a fibronectin receptor from Staphylococcus aureus. J. Biol. Acids Res. 17:3305.
Chem. 262:6564-6571. 43. Camilli, A., D. A. Portnoy, and P. Youngman. 1990. Insertional mutagene-
18. Lantz, M., R. D. Allen, P. Bounelis, L. M. Switalski, and M. Hook. 1990. sis of Listeria monocytogenes with a novel Tn917 derivative that allows direct
Bacteroides gingivalis and Bacteroides intermedius recognize different sites on cloning of DNA flanking transposon insertions. J. Bacteriol. 172:3738-3744.
human fibrinogen. J. Bacteriol. 172:716-726. 44. Nesin, M., P. Svec, J. R. Lupski, G. N. Godson, B. Kreiswirth, J. Korn-
19. Yeaman, M. R., P. M. Sullam, P. F. Dazin, D. C. Norman, and A. S. blum, and S. J. Projan. 1990. Cloning and nucleotide sequencing of a chromosom-
Bayer. 1992. Characterization of Staphylococcus aureus-platelet binding by quan- ally encoded tetracycline resistance determinant, tetA(M), from a pathogenic,
titative flow cytometric analysis. J. Infect. Dis. 166:65-73. methicillin resistant strain of Staphylococcus aureus. Antimicrob. Agents Chemo-
20. Clawson, C. C., J. G. White, and M. C. Herzberg. 1980. Platelet interaction ther. 34:2273-2276.